Interventional Cardiology Perspective

• Jun 09 2023 This Week in Cardiology   Impella, digital health, low-value processes, are tricuspid valve interventions with pacing leads are the topics Dr. John Mandrola, MD, discusses in this week's podcast.
  theheart.org on Medscape, June 09, 2023
• SCAI 2023 Read clinically focused news coverage of key developments from SCAI 2023
  theheart.org on Medscape, June 05, 2023
• Jun 02, 2023 This Week in Cardiology   Listener feedback on the most important study in a decade, MONITOR-HF, a flawed paper and analysis, and the tension between pathos and logos are the topics John Mandrola, MD discusses in this week's podcast.
  theheart.org on Medscape, June 02, 2023
• May 26 2023 This Week in Cardiology   An HRS meeting recap, Impella failure, sacubitril/valsartan, the purpose of trials, and a major breakthrough in evidence generation are the topics discussed by John Mandrola, MD in this week's podcast.
  theheart.org on Medscape, May 26, 2023
• ECG Challenge: Smoker With Severe Chest Pain A 49-year-old man is rushed to the ED with substernal chest pain and nausea. What does his ECG reveal?
  Medscape Cardiology, May 23, 2023
• May 19 2023 This Week in Cardiology   When to use an ICD, risk stratification for HCM, blending EP and structural cardiology to improve care in post-TAVI patients, and hsTroponins are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, May 19, 2023
• EuroPCR 2023 Read clinically focused news coverage of key developments from EuroPCR 2023
  theheart.org on Medscape, May 17, 2023
• May 12 2023 This Week in Cardiology   Two new papers on left atrial appendage occlusion, the promise of DNA, statins in the elderly, and SGLT2 inhibitors are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, May 12, 2023
• Ablation as First-Line Treatment for AF: 5 Things to Know Ablation is a mainstay of AF treatment, but disagreement persists regarding its use as a first-line option. In comparing study outcomes, we will explore how ablation is evolving and the rationale for it becoming first-line therapy for some patients with this debilitating arrhythmia.
  Medscape Cardiology, April 24, 2023
• EHRA 2023 Read clinically focused news coverage of key developments from EHRA 2023
  theheart.org on Medscape, April 17, 2023
• Apr 14 2023 This Week in Cardiology   SCAI consensus document on LAAC, semaglutide/tirzepatide disruption, NSAIDs, and interventional echocardiography are the topics discussed by John Mandrola, MD, on this week’s podcast.
  theheart.org on Medscape, April 14, 2023
• Why Aren't Clinicians Referring Patients to Cardiac Rehab? According to Dr Cate Collings, it's even financially feasible to start a cardiac rehab program in a primary care practice.
  Medscape Family Medicine, March 21, 2023
• Mar 10 2023 This Week in Cardiology   ACC Recap Part 1: Sports, bempedoic acid NASCARs, tricuspid regurgitation, and more on revascularization of stable CAD. are the topics discussed by John Mandrola, MD, in this week's podcast.
  theheart.org on Medscape, March 10, 2023
• Mar 03 2023 This Week in Cardiology   Renal denervation, AF ablation, omecamtiv mecarbil, and an ACC Preview are the topics discussed by John Mandrola, MD, in this week's podcast.
  theheart.org on Medscape, March 03, 2023
• Universal Testing for Lp(a): What Are We Waiting For? A retired cardiologist with a personal history with the atherogenic molecule calls for universal testing for lipoprotein (a).
  theheart.org on Medscape, February 01, 2023
• Jan 20 2023 This Week in Cardiology   The loop diuretic duels, adverse events during hospital admissions, BP accuracy, and left main revascularization strategies (again) are the topics John Mandrola discusses in this week’s podcast.
  theheart.org on Medscape, January 20, 2023
• Jan 6 2023 This Week in Cardiology   Damar Hamlin, obesity and semaglutide, Open Data and PCSK9 inhibitors, and TAVI vs SAVR trials are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, January 06, 2023
• Top Cardiology Trials of 2022   Trials on heart failure, hypertension and lipid-lowering drugs, and the evolution of antithrombin and antiplatelet therapy are discussed in part 2 of cardiologists Bob Harrington and Mike Gibson's annual review.
  theheart.org on Medscape, December 22, 2022
• Dec 16 2022 This Week in Cardiology   BP control over the long term, omecamtiv mecarbil, incentives and Goodhart’s law, and open science are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, December 16, 2022
• Mandrola’s Top 10 Cardiology Stories of 2022 A few dogmas felled, wins for meds, an exemplary trial, and clinical trends good and bad are covered in John Mandrola’s annual wrap up of cardiology stories for 2022.
  theheart.org on Medscape, December 15, 2022